| Optimal dose, timing and ratio of blood products in massive transfusion: results from a systematic review ZK McQuilten, G Crighton, S Brunskill, JK Morison, TH Richter, N Waters, ... Transfusion medicine reviews 32 (1), 6-15, 2018 | 132 | 2018 |
| Assessment of the urgency and deferability of transfusion to inform emergency blood planning and triage: the Bloodhound prospective audit of red blood cell use J Shortt, MN Polizzotto, N Waters, M Borosak, M Moran, M Comande, ... Transfusion 49 (11), 2296-2303, 2009 | 60 | 2009 |
| Profiling clinical platelet and plasma use to inform blood supply and contingency planning: PUPPY, the prospective utilization of platelets and plasma study PL Fedele, MN Polizzotto, G Grigoriadis, N Waters, M Comande, ... Transfusion 56 (10), 2455-2465, 2016 | 31 | 2016 |
| Demographic and socio-cultural correlates of medical mistrust in two Australian States: Victoria and South Australia A Renzaho, M Polonsky, Z McQuilten, N Waters Health & place 24, 216-224, 2013 | 31 | 2013 |
| Factors leading to health care exclusion among African refugees in Australia: the case of blood donation MJ Polonsky, AS Ferdous, AMN Renzaho, N Waters, Z McQuilten Journal of Public Policy & Marketing 37 (2), 306-326, 2018 | 30 | 2018 |
| The cost of blood: a study of the total cost of red blood cell transfusion in patients with β‐thalassemia using time‐driven activity‐based costing ZK McQuilten, AM Higgins, K Burns, S Chunilal, T Dunstan, HE Haysom, ... Transfusion 59 (11), 3386-3395, 2019 | 18 | 2019 |
| A time‐driven, activity‐based costing methodology for determining the costs of red blood cell transfusion in patients with beta thalassaemia major KE Burns, HE Haysom, AM Higgins, N Waters, R Tahiri, K Rushford, ... Transfusion Medicine 29 (1), 33-40, 2019 | 16 | 2019 |
| Major haemorrhage fatalities in the Australian national coronial database JS Gipson, EM Wood, MF Cole‐Sinclair, Z McQuilten, N Waters, ... Emergency Medicine Australasia 30 (3), 382-388, 2018 | 13 | 2018 |
| Blood donation by A frican migrants and refugees in A ustralia: the role of demographic and socio‐economic factors Z McQuilten, N Waters, M Polonsky, A Renzaho Vox sanguinis 106 (2), 137-143, 2014 | 13 | 2014 |
| Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naive and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND … Z McQuilten, S Heritier, L Fox, V Fox, L Young, P Blombery, I Cunningham, ... BMJ open 14 (1), e076246, 2024 | 5 | 2024 |
| Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancy ZK McQuilten, R Weinkove, LTP Thao, P Crispin, A Degelia, C Dendle, ... Blood Advances 8 (7), 1787-1795, 2024 | 4 | 2024 |
| Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel … LJ Estcourt, ZK McQuilten, P Bardy, M Cole-Sinclair, GP Collins, ... The Lancet Haematology 12 (1), e14-e22, 2025 | 3 | 2025 |
| Sickle cell disease in Australia: a snapshot from the Australian Haemoglobinopathy Registry A Nelson, PJ Ho, H Haysom, N Waters, C Wellard, M Chee, J Teo, ... Internal Medicine Journal 54 (5), 764-772, 2024 | 3 | 2024 |
| Rational: A randomised controlled feasibility trial comparing prophylactic immunoglobulin with antibiotics in patients with acquired hypogammaglobulinemia secondary to … Z McQuilten, R Weinkove, P Crispin, A Degelia, C Dendle, M Gilbertson, ... Lippincott Williams and Wilkins, 2021 | 3 | 2021 |
| Australians with chronic lymphocytic leukaemia continue to have high rates of second primary malignancies in the modern era D Baggio, E Chung, C Wellard, N Waters, T Cushion, G Chong, ... Internal medicine journal 54 (7), 1223-1227, 2024 | 1 | 2024 |
| Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies S Carrillo de Albornoz, AM Higgins, D Petrie, A Irving, L Fanning, ... Blood Advances 8 (9), 2259-2267, 2024 | 1 | 2024 |
| The Australian Aplastic Anaemia and other Bone Marrow Failure Syndromes Registry LC Fox, ZK McQuilten, F Firkin, V Fox, X Badoux, A Bajel, P Barbaro, ... Best Practice & Research Clinical Haematology, 101516, 2023 | 1 | 2023 |
| Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry D Baggio, C Wellard, E Chung, D Talaulikar, C Keane, S Opat, P Giri, ... Leukemia & Lymphoma 64 (3), 621-627, 2023 | 1 | 2023 |
| Understanding and meeting clinical platelet requirements: an analysis of indications and urgency of platelet use from the prospective utilisation of platelets and plasma (Puppy … N Polizzotto, N Waters, M Comande, G Grigoriadis, M Borosak, D Jolley HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 94, 455-456, 2009 | 1 | 2009 |
| PD23 Economic Evaluation Of Prophylactic Immunoglobulin Versus Prophylactic Antibiotics In Hematological Malignancies: Results From The RATIONAL Feasibility Trial SC De Albornoz, A Higgins, D Petrie, A Irving, L Fanning, R Weinkove, ... International Journal of Technology Assessment in Health Care 40 (S1), S106-S106, 2024 | | 2024 |
